Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital

被引：0
|
作者：
Roeland, Eric [1 ]
Hwang, Michael [1 ]
机构：
[1] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.563
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
563
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Octreotide Prescribing Patterns in the Palliation of Symptomatic Inoperable Malignant Bowel Obstruction Patients at a Single US Academic Hospital
    Roeland, Eric
    Hwang, Michael
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2013, 45 (02) : 373 - 374
  • [2] Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital
    Michael Hwang
    Rosene Pirrello
    Minya Pu
    Karen Messer
    Eric Roeland
    Supportive Care in Cancer, 2013, 21 : 2817 - 2824
  • [3] Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital
    Hwang, Michael
    Pirrello, Rosene
    Pu, Minya
    Messer, Karen
    Roeland, Eric
    SUPPORTIVE CARE IN CANCER, 2013, 21 (10) : 2817 - 2824
  • [4] Multicenter Prospective Study on Efficacy and Safety of Octreotide for Inoperable Malignant Bowel Obstruction
    Hisanaga, Takayuki
    Shinjo, Takuya
    Morita, Tatsuya
    Nakajima, Nobuhisa
    Ikenaga, Masayuki
    Tanimizu, Masahito
    Kizawa, Yoshiyuki
    Maeno, Takami
    Shima, Yasuo
    Hyodo, Ichinosuke
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (08) : 739 - 745
  • [5] Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction
    S. Mercadante
    C. Ripamonti
    A. Casuccio
    E. Zecca
    L. Groff
    Supportive Care in Cancer, 2000, 8 : 188 - 191
  • [6] Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction
    Mercadante, S
    Ripamonti, C
    Casuccio, A
    Zecca, E
    Groff, L
    SUPPORTIVE CARE IN CANCER, 2000, 8 (03) : 188 - 191
  • [7] Palliative Medical Management of Inoperable Malignant Bowel Obstruction With "Triple Therapy": Dexamethasone, Octreotide, and Metoclopramide
    Wey, Winston
    Mian, Moeena
    Calabrese, Rebecca
    Hansen, Eric
    Walter, Michelle
    Wang, Chong
    Miller, Austin
    Case, Amy A.
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2021, 38 (04): : 340 - 345
  • [8] HOME PARENTERAL-NUTRITION FOR PATIENTS WITH INOPERABLE MALIGNANT BOWEL OBSTRUCTION
    AUGUST, DA
    THORN, D
    FISHER, RL
    WELCHEK, CM
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1991, 15 (03) : 323 - 327
  • [9] Clinical Impact of Palliative Treatment Using Octreotide for Inoperable Malignant Bowel Obstruction Caused by Advanced Urological Cancer
    Kubota, Hiroki
    Taguchi, Kazumi
    Kobayashi, Daichi
    Naruyama, Hiromichi
    Hirose, Masahito
    Fukuta, Katsuhiro
    Kubota, Yasue
    Yasui, Takahiro
    Yamada, Yasuyuki
    Kohri, Kenjiro
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (12) : 7107 - 7110
  • [10] Management patterns and predictors of mortality among US patients with cancer hospitalized for malignant bowel obstruction
    Alese, Olatunji B.
    Kim, Sungjin
    Chen, Zhengjia
    Owonikoko, Taofeek K.
    El-Rayes, Bassel F.
    CANCER, 2015, 121 (11) : 1772 - 1778
12345